Establishment of a method for evaluating intracellular antibiotic efficacy in Brucella abortus-infected Mono Mac 6 monocytes
Open Access
- 16 November 2007
- journal article
- research article
- Published by Oxford University Press (OUP) in Journal of Antimicrobial Chemotherapy
- Vol. 61 (1) , 128-134
Abstract
Brucellae produce chronic and often lifelong infections in natural hosts. The persistent nature of these infections is predominantly due to the capacity of these bacteria to maintain intracellular residence in host macrophages. Successful antimicrobial therapy requires eradication of brucellae from this intracellular niche. It is important to seek new and improved antimicrobials for brucellosis therapy as well as a method to efficiently evaluate their intracellular efficacy. For that reason, we have developed a method to evaluate intracellular drug efficacy for new and improved antimicrobials that show initial in vitro activity against Brucella species during drug screening. Mono Mac 6 monocytes (MM6) were used because they are the only human cell line that constitutively expresses the phenotypic and functional characteristics of mature monocytes. This cell line has not previously been used with Brucella, therefore parallel studies were performed with J774 murine macrophages. Both cell lines were infected with Brucella abortus 2308 and antibiotics used clinically for treatment of brucellosis were used to determine intracellular efficacy. Significant differences in bacterial burden were observed at or above the MIC in both cell lines. Drug concentrations that fell below the MIC were found to significantly reduce intracellular brucellae only in MM6. The MM6 intracellular efficacy model will provide a useful method to examine the effect of novel antimicrobials for the treatment of human brucellosis.Keywords
This publication has 26 references indexed in Scilit:
- In vitro antimicrobial susceptibility of Brucella speciesInternational Journal of Antimicrobial Agents, 2004
- A short history of brucellosisVeterinary Microbiology, 2002
- Clinical Recognition and Management of Patients Exposed to Biological Warfare AgentsClinics In Laboratory Medicine, 2001
- Dipalmitoylphosphatidylcholine modulates inflammatory functions of monocytic cells independently of mitogen activated protein kinasesClinical and Experimental Immunology, 2001
- Brucella Bacteraemia: Clinical and Laboratory Observations in 160 PatientsJournal of Infection, 2000
- Neurobrucellosis: Clinical and Therapeutic FeaturesClinical Infectious Diseases, 1992
- Modern Chemotherapy for Brucellosis in HumansClinical Infectious Diseases, 1990
- Chemiluminescence in a Macrophage Cell Line Modulated by Biological Response ModifiersJournal of Leukocyte Biology, 1989
- Establishment of a human cell line (mono mac 6) with characteristics of mature monocytesInternational Journal of Cancer, 1988
- [24] Microassays for superoxide and hydrogen peroxide production and nitroblue tetrazolium reduction using an enzyme immunoassay microplate reader1986